Guilcher, G M T <br/><br/>
Single-agent high-dose melphalan followed by auto-SCT for relapsed and refractory Hodgkin lymphoma in children and adolescents.  [electronic resource] 

 -  Bone marrow transplantation  Mar 2012 
 - 395-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5365 
<br/><br/><label>Standard No.: </label>10.1038/bmt.2011.97  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Canada<br/>Child<br/>Drug Resistance, Neoplasm<br/>Female<br/>Hodgkin Disease--drug therapy<br/>Humans<br/>Lymphoma--therapy<br/>Male<br/>Melphalan--administration & dosage<br/>Myeloablative Agonists--administration & dosage<br/>Recurrence<br/>Retrospective Studies<br/>Stem Cell Transplantation--methods<br/>Transplantation Conditioning--methods